1.Expression changes of miRNAs in cerebral ischemia-reperfusion injury after deep hypothermic low flow in mice
Changfeng FAN ; Peicheng DING ; Weiyan ZHANG ; Zhongyuan WEN ; Di YU ; Song WANG ; Xuming MO
International Journal of Cerebrovascular Diseases 2015;(5):354-358
Objective To observe the expression changes of 12 ischemia-related microRNAs (miRNA) in cerebral ischemia-reperfusion injury after deep hypothermic low flow (DHLF) in mice.Methods A total of 80 3-w eek-old healthy and clean grade C57BL/6 male mice w ere randomly divided into either a DHLF model group or a sham operation group. Each group w as redivided into 4 subgroups according to the time points of 2, 6, 12, and 24 h (10 in each group). The bilateral carotid arteries of the DHLF model group w ere clipped and a DHLF model w as established, w hile the carotid arteries of the sham operation group w ere not clipped. The mice w ere sacrified at each time point and the brain tissue w as removed. The total RNA w as extracted. Quantitative reverse transcriptase polymerase chain reaction w as used to detect miRNA expression. Results Compared w ith the sham operation group, the expression levels of 9 miRNAs w ere upregulated, 2 w ere dow n-regulated, and 1 did not have any significant change in the DHLF model group. Conclusions The expression levels of 11 miRNAs changed significantly after DHLF. It might have a regulatory role in cerebral ischemia-reperfusion injury after DHLF.
2.A multi-center survey of hypertension and its treatment in patients with maintenance hemodialysis in Shanghai
Jing LIN ; Xiaoqiang DING ; Pan LIN ; Jianzhou ZOU ; Jie TENG ; Jinyuan ZHANG ; Niansong WANG ; Fujian ZHOU ; Peicheng SHEN ; Liqun HE ; Xiaorong BAO ; Shuren XU ; Huang YANG ; Jinghong ZHANG ; Kaiyuan ZHU ; Xinhua LI ; Gengru JIANG ; Wei ZHANG
Chinese Journal of Internal Medicine 2010;49(7):563-567
Objective To study the prevalence,treatment policy and control of hypertension in patients with maintenance hemodialysis, and to analyze the influencing factors of hypertension control.Methods We studied the current status of 1382 patients with maintenance hemodialysis in 11 dialysis centers in Shanghai, among them 809 were male, and 573 were female.Hypertension was defined as systolic blood pressure(SBP) ≥ 140 and/or diastolic blood pressure (DBP) ≥90 mm Hg ( 1 mm Hg = 0.133 kPa).Those who had a history of hypertension and requiring antihypertensive therapy were also diagnosed as hypertension though their blood pressure was within normal range during the survey.Hypertension control was defined as blood pressure < 140/90 mm Hg before each dialysis session.Results The prevalence of hypertension in the hemodialysis patients was 86.3%.The treatment rate and control rate in those patients were 96.8% and 25.5% respectively.More than half (50.4% ) of patients were treated with only one kind of anti-hypertensive drug, and 34.4% with 2 kinds, 14.2% with 3 kinds, 1.0% with 4 kinds or more.Calcium channel blocker (CCB) was the most frequently prescribed drug (61.0%), followed by angiotensin Ⅱ receptor blockers ( 56.4% ), centrally acting anti-hypertensive agent ( 26.4% ), beta blockers and alpha, beta-blockers( 14.0% ).The control rate of hypertension in those hemodialysis people was aggravated by the existence of coronary artery disease.The patients who need more kinds of antihypertensive agents have a poorer control rate of hypertension.The hypertension control rate elevated significantly with the adequate hemodialysis.Conclusions There is a very high prevalence of hypertension in maintenance hemodialysis patients.Although the treatment rate is high, the control rate is unsatisfactory.So the control of hypertension in hemodialysis patient is still a clinical challenge.Appropriate dialysis adequacy, reasonable use of erythropoietin, treatment of heart disease and judicious use of antihypertensive drugs may be helpful to improve the clinical outcome.
3.Surgical treatment and follow up for pediatric patients with primary cardiac tumors
Peicheng DING ; Xuming MO ; Ji-Rong QI
Chinese Journal of Thoracic and Cardiovascular Surgery 2018;34(1):32-35
Objective To summarize the experience in surgical treatment of primary cardiac tumors in children .Meth-ods Retrospective analysis of 13 children with primary cardiac tumors which were surgically treated in our department from June 1994 to March 2016.Among the 13 patients, 8 were boys and 5 were girls.The mean and standard deviation(range) of age was(4.85 ±4.61) years(5 days -13 years).The diagnosis was identified by echocardiography and computed tomography before operation and by pathological diagnosis after operation .All patients were followed up after discharge .Results A num-ber of 13 patients underwent surgical treatment.One patient died from cardiac failure after surgery.Histologic examination re-vealed rhabdomyoma in 8 patients, myxoma in 2 patients, fibroma in 2 patients, and rhabdomyosarcoma in 1 patient.All the remaining 12 patients followed up for(85.71 ±17.04) months(3-247 months), one patient with benign tumor was relapsed without tumor-related symptoms, the other patient with malignant tumor was relapsed and died from abandoning treatment .Oth-ers had good cardiac function and symptom improvement .Conclusion Primary cardiac tumors in children are mostly primarily benign.Tumors with different characteristics get different clinical symptoms and prognosis .Personalized therapy strategies need to be performed to achieve better outcomes .